Literature DB >> 11348969

Clinical utility of the exercise ECG in patients with diabetes and chest pain.

D P Lee1, W F Fearon, V F Froelicher.   

Abstract

OBJECTIVE: The purpose of this study was to determine the characteristics of exercise treadmill testing in diabetic patients presenting with chest pain.
BACKGROUND: The diagnosis of coronary artery disease (CAD) in diabetic patients is confounded by different manifestations of coronary disease than are seen in the general population. Because of the association of diabetes with accelerated CAD, it is critical to assess the diagnostic utility of the standard exercise test in diabetic patients with chest pain.
METHODS: This study was a retrospective analysis of standard exercise test results in 1,282 male patients without prior myocardial infarction who had undergone coronary angiography and were being evaluated for possible CAD at two Veterans' Administration institutions.
RESULTS: In patients with diabetes, 38% had an abnormal exercise test result, and the prevalence of angiographic CAD was 69%; the sensitivity of the exercise test was 47% (95% confidence interval [CI], 41 to 58), and specificity was 81% (95% CI, 68 to 89). In patients without diabetes, 38% had an abnormal exercise test result, and the prevalence of angiographic CAD was 58%; the sensitivity of the exercise test was 52% (95% CI, 48 to 56), and specificity was 80% (95% CI, 76 to 83). The receiver operating characteristic curves were also similar in both diabetic and nondiabetic patients (0.67 and 0.68, respectively).
CONCLUSION: These data demonstrate that the standard exercise test has similar diagnostic characteristics in diabetic as in nondiabetic patients.

Entities:  

Mesh:

Year:  2001        PMID: 11348969     DOI: 10.1378/chest.119.5.1576

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  9 in total

Review 1.  Subclinical cardiovascular disease in type 2 diabetes mellitus: To screen or not to screen.

Authors:  Juan J Chillarón; Juana A Flores-Le Roux; David Benaiges; Juan Pedro-Botet
Journal:  World J Clin Cases       Date:  2014-09-16       Impact factor: 1.337

2.  Diagnosis of coronary artery disease in persons with diabetes mellitus.

Authors:  Nima Alipour; Nathan D Wong; Shaista Malik
Journal:  Curr Diab Rep       Date:  2012-06       Impact factor: 4.810

Review 3.  Assessment of cardiovascular risk in diabetes: Risk scores and provocative testing.

Authors:  Teresa Lam; Kharis Burns; Mark Dennis; N Wah Cheung; Jenny E Gunton
Journal:  World J Diabetes       Date:  2015-05-15

4.  Maximal exercise electrocardiography responses and coronary heart disease mortality among men with diabetes mellitus.

Authors:  G William Lyerly; Xuemei Sui; Timothy S Church; Carl J Lavie; Gregory A Hand; Steven N Blair
Journal:  Circulation       Date:  2008-05-19       Impact factor: 29.690

Review 5.  Value of Exercise ECG for Risk Stratification in Suspected or Known CAD in the Era of Advanced Imaging Technologies.

Authors:  Jamieson M Bourque; George A Beller
Journal:  JACC Cardiovasc Imaging       Date:  2015-11

6.  Silent myocardial ischemia is associated with autonomic neuropathy and other cardiovascular risk factors in type 1 and type 2 diabetic subjects, especially in those with microalbuminuria.

Authors:  Ana Chico; Antoni Tomás; Anna Novials
Journal:  Endocrine       Date:  2005-08       Impact factor: 3.925

7.  Impact of Diabetes Mellitus on the Evaluation of Stable Chest Pain Patients: Insights From the PROMISE (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) Trial.

Authors:  Abhinav Sharma; Nishant K Sekaran; Adrian Coles; Neha J Pagidipati; Udo Hoffmann; Daniel B Mark; Kerry L Lee; Hussein R Al-Khalidi; Michael T Lu; Patricia A Pellikka; Quynh A Truong; Pamela S Douglas
Journal:  J Am Heart Assoc       Date:  2017-10-31       Impact factor: 5.501

8.  Identification of Silent Myocardial Ischemia in Patients with Long-Term Type 1 and Type 2 Diabetes.

Authors:  Dominika Rokicka; Anna Bożek; Marta Wróbel; Alicja Nowowiejska-Wiewióra; Aleksandra Szymborska-Kajanek; Tomasz Stołtny; Mariusz Gąsior; Krzysztof Strojek
Journal:  Int J Environ Res Public Health       Date:  2022-01-27       Impact factor: 3.390

9.  Interleukin-6 and activin A are independently associated with cardiovascular events and mortality in type 2 diabetes: the prospective Asker and Bærum Cardiovascular Diabetes (ABCD) cohort study.

Authors:  Anne Pernille Ofstad; Lars Gullestad; Elsa Orvik; Svend Aakhus; Knut Endresen; Thor Ueland; Pål Aukrust; Morten W Fagerland; Kåre I Birkeland; Odd Erik Johansen
Journal:  Cardiovasc Diabetol       Date:  2013-08-30       Impact factor: 9.951

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.